Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line treatment for metastatic kidney cancer
Treatment of advanced (metastatic) kidney cancer has improved considerably over [...]
Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes
A recent phase 2 clinical trial presented at the 2025 [...]
Screening programme to be extended to Wakefield
Hundreds of people in Wakefield and across the region will [...]
Cabozantinib most promising for refractory metastatic kidney cancer
In a European study of second-line treatments for metastatic kidney [...]
Combination therapy shows promise for hereditary papillary kidney cancer
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated papillary RCC is [...]
Kidney cancer becoming more common in younger people?
A study conducted by American researchers has identified an increase [...]
UK regulators approve injectable form of nivolumab for solid tumours
The Medicines and Healthcare products Regulatory Agency (MHRA) in the [...]
Europe has approved subcutaneous nivolumab for solid tumours
The Committee for Medicinal Products for Human Use (CHMP) of [...]
A urine test to detect the return of kidney cancer
A study has shown that a simple urine test could [...]
Health-related quality of life with belzutifan versus everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
